Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Adaptive Biotechnologies
ADPT
$3.91B
| $596K | ﹤0.01% |
73,719
+35,276
| +92% | +$310K |
|
2652
NETGEAR
NTGR
$654M
| $595K | ﹤0.01% |
32,105
-14,339
| -31% | -$293K |
|
2653
ADT
ADT
$5.63B
| $594K | ﹤0.01% |
96,501
+22,056
| +30% | +$154K |
|
2654
Spire
SR
$4.78B
| $593K | ﹤0.01% |
7,982
-82,665
| -91% | -$6.22M |
|
2655
Old Second Bancorp
OSBC
$1.32B
| $592K | ﹤0.01% |
44,276
+3,084
| +7% | +$44K |
|
2656
Artivion
AORT
$1.27B
| $590K | ﹤0.01% |
31,260
-18,802
| -38% | -$363K |
|
|
ONEM
2657
DELISTED
1Life Healthcare
ONEM
| $590K | ﹤0.01% |
75,221
-8,227
| -10% | -$70.7K |
|
2658
Fulgent Genetics
FLGT
$526M
| $589K | ﹤0.01% |
10,785
-9,253
| -46% | -$509K |
|
|
TRCA
2659
DELISTED
Twin Ridge Capital Acquisition Corp.
TRCA
| $589K | ﹤0.01% |
+59,998
| New | +$588K |
|
2660
Photronics
PLAB
$1.89B
| $588K | ﹤0.01% |
30,196
-29,010
| -49% | -$508K |
|
2661
Asana
ASAN
$2.05B
| $585K | ﹤0.01% |
33,327
-34,890
| -51% | -$878K |
|
|
TGAAU
2662
DELISTED
Target Global Acquisition I Corp. Unit
TGAAU
| $585K | ﹤0.01% |
58,646
| – | – |
|
|
SJR
2663
DELISTED
Shaw Communications Inc.
SJR
| $583K | ﹤0.01% |
19,770
-77,617
| -80% | -$2.25M |
|
2664
Southern First Bancshares
SFST
$608M
| $582K | ﹤0.01% |
13,353
+841
| +7% | +$38.2K |
|
|
SRSA
2665
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
| $582K | ﹤0.01% |
58,890
| – | – |
|
2666
ICU Medical
ICUI
$4.16B
| $581K | ﹤0.01% |
3,536
-28,402
| -89% | -$5.47M |
|
|
FLNA
2667
Filana Therapeutics
FLNA
$46.4M
| $581K | ﹤0.01% |
20,640
-3,621
| -15% | -$91.4K |
|
|
TRTX
2668
TPG RE Finance Trust
TRTX
$610M
| $580K | ﹤0.01% |
64,360
+29,379
| +84% | +$308K |
|
2669
TD Synnex
SNX
$21B
| $579K | ﹤0.01% |
6,365
+5,040
| +380% | +$501K |
|
|
JKS
2670
JinkoSolar
JKS
$826M
| $576K | ﹤0.01% |
8,324
-135,672
| -94% | -$7.61M |
|
2671
ARKO Corp
ARKO
$826M
| $575K | ﹤0.01% |
70,463
+56,679
| +411% | +$494K |
|
2672
First Business Financial Services
FBIZ
$601M
| $575K | ﹤0.01% |
18,415
-2,086
| -10% | -$69.6K |
|
|
AL
2673
DELISTED
Air Lease Corp
AL
| $574K | ﹤0.01% |
17,181
+4,956
| +41% | +$188K |
|
2674
abrdn Physical Gold Shares ETF
SGOL
$7.25B
| $574K | ﹤0.01% |
33,130
| – | – |
|
2675
Smith & Wesson
SWBI
$658M
| $573K | ﹤0.01% |
43,650
-635
| -1% | -$9.21K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.